Liposomal delivery is a formulation approach where an active compound is enclosed within small lipid vesicles, often phosphatidylcholine-based, with the intent of changing how the compound survives the gut and how it is taken up. The vesicle is the carrier; the active compound is what users care about, and the actual behavior depends on both. Format choice intersects with bioavailability, so it deserves the same gated reading that bioavailability entry recommends rather than a flat "absorbs better" assumption.
What a liposome is and is not
A liposome is a microscopic bilayer vesicle that can carry water-soluble or fat-soluble compounds. In a finished supplement, particle size, vesicle stability across shelf life, and the proportion of active actually encapsulated all vary by manufacturer and by batch. A label that says "liposomal" tells you the intended format, not necessarily the encapsulation efficiency in the bottle on the shelf.
Where evidence is stronger and weaker
For some compounds, including glutathione, vitamin C ascorbate products, and certain forms of curcumin, liposomal forms have shown changes in plasma response in published studies, and the understanding supplement categories overview describes how to read those category-level claims. Evidence is uneven across ingredients, and study quality varies, so a claim of "more bioavailable" should be read against the specific compound, the specific product, and the specific outcome studied, not against the category. Third-party testing and Certificates of Analysis are the documents that bridge the marketing claim and the bottle.
Practical reading of liposomal labels
Look for the lipid source, an encapsulation percentage if disclosed, the active compound amount per serving, and whether the actives are listed on the front panel or hidden behind a non-disclosed inner mixture. If the only specific number on the label is the total weight of the lipid-active mixture, the per-ingredient active dose is unknown.
Uncertainty and limits
Stability matters. Liposomes can degrade with heat, freezing, agitation, and time. Evidence is limited on whether a stored bottle still meets the encapsulation claimed on the day of manufacture.
How this appears in Unfair
Unfair stores liposomal as a distinct format on library entries and treats compound-specific evidence rather than the format alone as the basis for any ranking. The format flag flows into the duplicate-and-overlap checks and is not used as a free assumption of higher response.
Clinical safety note
If a liposomal product produces nausea, GI distress, or a hypersensitivity-like reaction (often related to soy or sunflower lecithin sources), pause the product, check the lipid source on the label, and confirm with a clinician before reintroducing.